311 related articles for article (PubMed ID: 35124126)
21. Overcoming the Challenges of siRNA Delivery: Nanoparticle Strategies.
Shajari N; Mansoori B; Davudian S; Mohammadi A; Baradaran B
Curr Drug Deliv; 2017; 14(1):36-46. PubMed ID: 27538460
[TBL] [Abstract][Full Text] [Related]
22. Targeting the innate immune system with nanoparticles for cancer immunotherapy.
Li K; Zhang Z; Mei Y; Li M; Yang Q; Wu Q; Yang H; He L; Liu S
J Mater Chem B; 2022 Mar; 10(11):1709-1733. PubMed ID: 35179545
[TBL] [Abstract][Full Text] [Related]
23. Advances in nanoparticle-based mRNA delivery for liver cancer and liver-associated infectious diseases.
Chung S; Lee CM; Zhang M
Nanoscale Horiz; 2022 Dec; 8(1):10-28. PubMed ID: 36260016
[TBL] [Abstract][Full Text] [Related]
24. [Development of a Nano DDS for Cancer Immunotherapy Based on Llipid Nanoparticles].
Nakamura T
Yakugaku Zasshi; 2018; 138(12):1443-1449. PubMed ID: 30504656
[TBL] [Abstract][Full Text] [Related]
25. Advances in the polymeric nanoparticulate delivery systems for RNA therapeutics.
Sristi ; Almalki WH; Karwasra R; Gupta G; Singh S; Sharma A; Sahebkar A; Kesharwani P
Prog Mol Biol Transl Sci; 2024; 204():219-248. PubMed ID: 38458739
[TBL] [Abstract][Full Text] [Related]
26. Smart drug delivery systems to overcome drug resistance in cancer immunotherapy.
Yi W; Yan D; Wang D; Li Y
Cancer Biol Med; 2023 May; 20(4):248-67. PubMed ID: 37144580
[TBL] [Abstract][Full Text] [Related]
27. Nanotechnology platforms for cancer immunotherapy.
Yang Z; Ma Y; Zhao H; Yuan Y; Kim BYS
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2020 Mar; 12(2):e1590. PubMed ID: 31696664
[TBL] [Abstract][Full Text] [Related]
28. Harnessing the immune system to fight cancer with Toll-like receptor and RIG-I-like receptor agonists.
Bourquin C; Pommier A; Hotz C
Pharmacol Res; 2020 Apr; 154():104192. PubMed ID: 30836160
[TBL] [Abstract][Full Text] [Related]
29. Non-viral gene delivery for cancer immunotherapy.
Wang W; Saeed M; Zhou Y; Yang L; Wang D; Yu H
J Gene Med; 2019 Jul; 21(7):e3092. PubMed ID: 30991453
[TBL] [Abstract][Full Text] [Related]
30. Nanoparticles as Smart Carriers for Enhanced Cancer Immunotherapy.
Thakur N; Thakur S; Chatterjee S; Das J; Sil PC
Front Chem; 2020; 8():597806. PubMed ID: 33409265
[TBL] [Abstract][Full Text] [Related]
31. Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems.
Gencer A; Duraloglu C; Ozbay S; Ciftci TT; Yabanoglu-Ciftci S; Arica B
Curr Drug Deliv; 2021; 18(2):103-120. PubMed ID: 32748745
[TBL] [Abstract][Full Text] [Related]
32. Multistage Self-Assembled Nanomaterials for Cancer Immunotherapy.
Guo L; Yang J; Wang H; Yi Y
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067480
[TBL] [Abstract][Full Text] [Related]
33. Nanocarriers: Exploring the Potential of Oligonucleotide Delivery.
Alsaidan OA
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38918987
[TBL] [Abstract][Full Text] [Related]
34. Combining Nanomedicine and Immunotherapy.
Shi Y; Lammers T
Acc Chem Res; 2019 Jun; 52(6):1543-1554. PubMed ID: 31120725
[TBL] [Abstract][Full Text] [Related]
35. A drug delivery strategy emerges that has the potential to transform cancer therapy.
Theobald N; Templeton D
Drug Discov Today; 2024 Apr; 29(4):103923. PubMed ID: 38401877
[TBL] [Abstract][Full Text] [Related]
36. Metallic Nanoparticle-Mediated Immune Cell Regulation and Advanced Cancer Immunotherapy.
Mohapatra A; Sathiyamoorthy P; Park IK
Pharmaceutics; 2021 Nov; 13(11):. PubMed ID: 34834282
[TBL] [Abstract][Full Text] [Related]
37. Nano Drug Delivery System for Tumor Immunotherapy: Next-Generation Therapeutics.
Zhou L; Zou M; Xu Y; Lin P; Lei C; Xia X
Front Oncol; 2022; 12():864301. PubMed ID: 35664731
[TBL] [Abstract][Full Text] [Related]
38. Lipid Nanoparticles for mRNA Delivery to Enhance Cancer Immunotherapy.
Wang HL; Wang ZG; Liu SL
Molecules; 2022 Aug; 27(17):. PubMed ID: 36080373
[TBL] [Abstract][Full Text] [Related]
39. Injectable Immunotherapeutic Hydrogel Containing RNA-Loaded Lipid Nanoparticles Reshapes Tumor Microenvironment for Pancreatic Cancer Therapy.
Gao C; Cheng K; Li Y; Gong R; Zhao X; Nie G; Ren H
Nano Lett; 2022 Nov; 22(22):8801-8809. PubMed ID: 36251255
[TBL] [Abstract][Full Text] [Related]
40. Targeted drug delivery system for ovarian cancer microenvironment: Improving the effects of immunotherapy.
Peng H; He X; Wang Q
Front Immunol; 2022; 13():1035997. PubMed ID: 36405688
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
